PHIO
PHIO
NASDAQ · Biotechnology

Phio Pharmaceuticals Corp

$1.25
+0.05 (+4.17%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +2,508.8% upside
Low Target $25.28
Average Target $32.61
High Target $46.79
Current Price $1.25
Current
$1.25
Target
$32.61
$25.28 $32.61 avg $46.79
Scenario Analysis
Bear Case
$25.28
1,922.4%
Low target
Base Case
$32.61
+2,508.8%
Avg target
Bull Case
$46.79
+3,643.2%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$4.19
-70.2% from high
52-Week Low
$0.81
+53.8% from low
Target vs 52W High
$32.61
+678.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +18.4%
AMGN
Amgen Inc
Hold 42 50% $190.87 -45.8%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +160.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -1.8%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.1%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -28.5%